Follow
Adam Finn
Adam Finn
Professor of Paediatrics
Verified email at bristol.ac.uk
Title
Cited by
Cited by
Year
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10269), 99-111, 2021
52162021
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, ...
The Lancet 396 (10249), 467-478, 2020
27342020
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four …
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10277), 881-891, 2021
13082021
Chemokine receptors and their role in inflammation and infectious diseases
C Murdoch, A Finn
Blood, The Journal of the American Society of Hematology 95 (10), 3032-3043, 2000
12082000
SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses
W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ...
Cell 185 (3), 467-484. e15, 2022
8832022
Valganciclovir for symptomatic congenital cytomegalovirus disease
DW Kimberlin, PM Jester, PJ Sánchez, A Ahmed, R Arav-Boger, ...
New England Journal of Medicine 372 (10), 933-943, 2015
7712015
Clinical spectrum of X-linked hyper-IgM syndrome
J Levy, T Espanol-Boren, C Thomas, A Fischer, P Tovo, P Bordigoni, ...
The Journal of pediatrics 131 (1), 47-54, 1997
7571997
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B. 1.1. 7): an exploratory analysis of a randomised controlled trial
KRW Emary, T Golubchik, PK Aley, CV Ariani, B Angus, S Bibi, B Blane, ...
The Lancet 397 (10282), 1351-1362, 2021
7292021
Mapping the human genetic architecture of COVID-19
Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ...
Nature 600 (7889), 472-477, 2021
7002021
Interleukin-17A mediates acquired immunity to pneumococcal colonization
YJ Lu, J Gross, D Bogaert, A Finn, L Bagrade, Q Zhang, JK Kolls, ...
PLoS pathogens 4 (9), e1000159, 2008
5612008
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised …
X Liu, RH Shaw, ASV Stuart, M Greenland, PK Aley, NJ Andrews, ...
The Lancet 398 (10303), 856-869, 2021
4812021
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ...
Medrxiv, 2021.06. 15.21258542, 2021
475*2021
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ...
The Lancet 397 (10285), 1637-1645, 2021
467*2021
Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass
A Finn, S Naik, N Klein, RJ Levinsky, S Strobel, M Elliott
The Journal of Thoracic and Cardiovascular Surgery 105 (2), 234-241, 1993
3891993
Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization …
N Gossger, MD Snape, LM Yu, A Finn, G Bona, S Esposito, N Principi, ...
Jama 307 (6), 573-582, 2012
3652012
Cxc chemokine receptor expression on human endothelial cells
C Murdoch, PN Monk, A Finn
Cytokine 11 (9), 704-712, 1999
3421999
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group
Lancet (London, England) 397 (10274), 605, 2021
3132021
Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial
RC Read, D Baxter, DR Chadwick, SN Faust, A Finn, SB Gordon, ...
The Lancet 384 (9960), 2123-2131, 2014
3022014
Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre …
CD Russell, CJ Fairfield, TM Drake, L Turtle, RA Seaton, DG Wootton, ...
The Lancet Microbe 2 (8), e354-e365, 2021
2762021
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)
A Flaxman, NG Marchevsky, D Jenkin, J Aboagye, PK Aley, B Angus, ...
The Lancet 398 (10304), 981-990, 2021
2682021
The system can't perform the operation now. Try again later.
Articles 1–20